ABIONYX Pharma SA's market cap is currently €42.82M. The company's EPS TTM is €-0.105; its P/E ratio is ―; ABIONYX Pharma SA is scheduled to report earnings on March 6, 2025, and the estimated EPS forecast is €―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	€ 4.64M	€ 5.25M	€ 675.00K	€ 0.00	€ 0.00
Gross Profit	€ 618.00K	€ 636.00K	€ 259.00K	€ -80.00K	€ -72.00K
Operating Income	€ -3.41M	€ -4.11M	€ -5.95M	€ -2.97M	€ 2.24M
EBITDA	€ -3.29M	€ -3.99M	€ -5.83M	€ -2.33M	€ 1.80M
Net Income	€ -3.52M	€ -4.30M	€ -5.83M	€ -1.89M	€ 1.85M
Balance Sheet
Cash & Short-Term Investments	€ 4.10M	€ 4.05M	€ 7.93M	€ 9.15M	€ 8.33M
Total Assets	€ 14.83M	€ 15.82M	€ 21.83M	€ 10.29M	€ 10.25M
Total Debt	€ 3.39M	€ 4.01M	€ 4.96M	€ 24.00K	€ 1.18M
Net Debt	€ -714.00K	€ -33.00K	€ -2.98M	€ -9.13M	€ -7.15M
Total Liabilities	€ 6.91M	€ 8.65M	€ 11.15M	€ 3.66M	€ 3.58M
Stockholders' Equity	€ 7.92M	€ 7.17M	€ 10.68M	€ 6.63M	€ 6.67M
Cash Flow
Free Cash Flow	€ -3.83M	€ -3.53M	€ -6.86M	€ -747.00K	€ -3.95M
Operating Cash Flow	€ -3.70M	€ -3.36M	€ -6.69M	€ -599.00K	€ -3.95M
Investing Cash Flow	€ -130.00K	€ -175.00K	€ 1.34M	€ -125.00K	€ 0.00
Financing Cash Flow	€ 3.89M	€ -194.00K	€ 3.97M	€ 1.55M	€ 823.00K

Currency in EUR

ABIONYX Pharma SA Earnings and Revenue History

Income Statement >

ABIONYX Pharma SA Debt to Assets

Balance Sheet >

ABIONYX Pharma SA Cash Flow

Cash Flow >

ABIONYX Pharma SA Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing